BioHarvest Sciences Inc. ... (BHST)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 5.4 |
Market Cap | 94.13M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.28 |
PE Ratio (ttm) | -4.24 |
Forward PE | n/a |
Analyst | Buy |
Ask | 5.69 |
Volume | 1,252 |
Avg. Volume (20D) | 9,433 |
Open | 5.71 |
Previous Close | 5.60 |
Day's Range | 5.40 - 5.71 |
52-Week Range | 0.00 - 7.38 |
Beta | undefined |
About BHST
A detailed description of the company is not yet available....
Analyst Forecast
According to 2 analyst ratings, the average rating for BHST stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 139.31% from the latest price.
News

2 weeks ago · proactiveinvestors.com
BioHarvest Sciences appoints veteran technology leader to board of directorsBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) has announced the appointment of seasoned technology executive Sharon Malka as an independent director of the company. Malka brings extensive leadershi...

2 weeks ago · newsfilecorp.com
BioHarvest Announces Appointment of Sharon Malka to Board of DirectorsVeteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 22, 2025) - BioHarvest Sc...

2 weeks ago · proactiveinvestors.com
BioHarvest Sciences positioned for ‘legacy year' in 2025, building on momentum with new innovations and strategic collaborationsBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) is poised to capitalize on key trends shaping the health and wellness industry in 2025, including a growing focus on sustainability, longevity-driven h...

4 weeks ago · proactiveinvestors.com
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growthBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) CEO Ilan Sobel has reflected on 2024 as “a year of transformation and growth” for the company. In a letter to shareholders, Sobel highlighted the launc...

4 weeks ago · newsfilecorp.com
BioHarvest Issues Shareholder Letter and Provides Corporate UpdateVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc. , (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pione...

1 month ago · proactiveinvestors.com
BioHarvest Sciences CEO discusses Tate & Lyle partnership - ICYMIBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) this week announced a significant move for the company, a partnership with Tate & Lyle to develop plant-based sweeteners. The collaboration aims to cre...

1 month ago · proactiveinvestors.com
BioHarvest Sciences partners with Tate & Lyle to advance plant-based sweetenersBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) announced it has partnered with Tate & Lyle PLC (LSE:TATE) to develop proprietary plant-based molecules for food and beverage ingredients. The partners...

2 months ago · seekingalpha.com
BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call TranscriptBioHarvest Sciences Inc. (NASDAQ:BHST ) Q3 2024 Earnings Conference Call November 25, 2024 4:30 PM ET Company Participants Justin Meiklem - IR Ilan Sobel - CEO Bar Dichter - CFO Zaki Rakib - President...

2 months ago · proactiveinvestors.com
BioHarvest Sciences reports increased revenues, profits for Q3BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) reported robust financial performance for the third quarter ending September 30, 2024. The company achieved a 101% year-over-year revenue increase to $6....

2 months ago · newsfilecorp.com
BioHarvest Sciences Reports Third Quarter 2024 Financial ResultsThird Quarter 2024 Revenue Increased 101% Year-over-Year to Over $6.5 Million, Exceeding Management Guidance Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - Bio...